copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Our leaders | Edwards Lifesciences Bernard J Zovighian is CEO and on the Board of Directors of Edwards Lifesciences since May 2023, after serving as the company’s president As CEO, Zovighian is leading Edwards into a new era of groundbreaking structural heart innovation, with a sharpened focus and pursuit of expanded opportunities to transform the care of structural heart patients worldwide Building from Edwards
Edwards Lifesciences to Sell Critical Care to BD IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4 2 billion With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care Edwards will use the after
Edwards Lifesciences Corp - Edwards Lifesciences Appoints Aimee Weisner . . . IRVINE, CA, January 12, 2011 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the appointment of Aimee S Weisner as corporate vice president, general counsel Weisner will lead the company's legal organization and will report to Edwards' chairman and CEO, Michael A Mussallem Bruce P Garren, who has
Search Jobs | Edwards Lifesciences Edwards Lifesciences is an equal opportunity employer We believe that diversity and inclusion are essential to creating an environment where all our employees can grow and thrive Guided by our values of integrity and service, we are committed to maintaining a culture of inclusivity and belonging by creating a welcoming workplace for people of all backgrounds Edwards Lifesciences is
Locations - Edwards Lifesciences Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient Interested in a position at Edwards Lifesciences? We have opportunities around the world See where a career with Edwards could take you
Press Releases | Edwards Lifesciences TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
Senior Manager, Supplier Quality | Edwards Lifesciences The Senior Manager, Supplier Quality will provide direction and oversight of all of the production supplier quality activities, including interacting with receiving inspection, NCRs on supplier materials, managing supplier relationships, working with suppliers on corrective actions and changes to supplier processes, as well as incorporating new product introductions into the production
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral . . . IRVINE, Calif -- (BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy Leveraging the company